Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Allogene Therapeutics, Inc. (ALLO)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-05-18
   10-K10-K10-K10-K10-K8-K
Revenues  0.238.50.00.00.0151.9
            Revenue growth  -99.4%     
Cost of goods sold  0.00.00.00.00.0192.8
Gross profit  0.238.50.00.00.0-41.0
            Gross margin  100.0%100.0%   -27.0%
Selling, general and administrative   [+]79.374.165.357.541.041.0
Research and development  256.4220.2193.0144.5151.9 
Other operating expenses       110.9
EBITDA   [+]-321.2-245.3-250.7-197.0-191.3 
            EBITDA margin  -132162.1%-637.4%   -127.0%
Depreciation  14.310.57.44.41.0 
EBITA  -335.4-255.8-258.1-201.4-192.4-192.8
            EBITA margin  -138044.9%-664.6%   -127.0%
Amortization of intangibles    0.20.60.5 
EBIT   [+]-335.4-255.8-258.2-202.0-192.8-192.8
            EBIT margin  -138044.9%-664.6%   -127.0%
Interest income, net   [+]4.61.79.2 -3.4-3.4
Other income (expense), net  -1.7-2.9-1.117.1-15.4-15.4
Pre-tax income  -332.6-257.0-250.2-184.9-211.6-211.6
Income taxes  0.00.00.0-0.3-0.1-0.1
            Tax rate  0.0%0.0%0.0%0.2%0.1%0.1%
Net income  -332.6-257.0-250.2-184.6-211.5-211.5
            Net margin  -136885.6%-667.7%   -139.3%
   
Basic EPS   [+]($2.32)($1.89)($2.08)($1.83)($7.31)($7.31)
Diluted EPS   [+]($2.32)($1.89)($2.08)($1.83)($7.31)($7.31)
   
Shares outstanding (basic)   [+]143.1135.8120.4101.128.928.9
Shares outstanding (diluted)   [+]143.1135.8120.4101.128.928.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy